世界の向精神薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Psychotropic Drug Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4785
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、向精神薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、麻酔薬、催眠薬、その他）、用途別市場規模（病院薬局、小売薬局、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・向精神薬の市場動向
・企業の競争状況、市場シェア
・向精神薬の種類別市場規模と予測2016-2027（鎮痛薬、麻酔薬、催眠薬、その他）
・向精神薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、オンライン薬局）
・向精神薬の北米市場規模2016-2027（アメリカ、カナダ）
・向精神薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・向精神薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・向精神薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・向精神薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer、Ely Lilly、Actavis、Mylan、Randox、Fujifilm）
・結論

The majority of essential psychotropic drugs are indicated to treat symptoms of mental disorders, slow down course of mental disorders, diminish disability and avoid relapse in a patient.

Market Analysis and Insights: Global Psychotropic Drug Market
The global Psychotropic Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Psychotropic Drug market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Psychotropic Drug market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Psychotropic Drug market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Psychotropic Drug market.

Global Psychotropic Drug Scope and Market Size
Psychotropic Drug market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Psychotropic Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Analgesics
Anesthetics
Hypnotics
Others

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer
Ely Lilly
Actavis
Mylan
Randox
Fujifilm

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Psychotropic Drug Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Anesthetics
1.2.4 Hypnotics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Psychotropic Drug Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Psychotropic Drug Market Perspective (2016-2027)
2.2 Psychotropic Drug Growth Trends by Regions
2.2.1 Psychotropic Drug Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Psychotropic Drug Historic Market Share by Regions (2016-2021)
2.2.3 Psychotropic Drug Forecasted Market Size by Regions (2022-2027)
2.3 Psychotropic Drug Industry Dynamic
2.3.1 Psychotropic Drug Market Trends
2.3.2 Psychotropic Drug Market Drivers
2.3.3 Psychotropic Drug Market Challenges
2.3.4 Psychotropic Drug Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Psychotropic Drug Players by Revenue
3.1.1 Global Top Psychotropic Drug Players by Revenue (2016-2021)
3.1.2 Global Psychotropic Drug Revenue Market Share by Players (2016-2021)
3.2 Global Psychotropic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Psychotropic Drug Revenue
3.4 Global Psychotropic Drug Market Concentration Ratio
3.4.1 Global Psychotropic Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Psychotropic Drug Revenue in 2020
3.5 Psychotropic Drug Key Players Head office and Area Served
3.6 Key Players Psychotropic Drug Product Solution and Service
3.7 Date of Enter into Psychotropic Drug Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Psychotropic Drug Breakdown Data by Type
4.1 Global Psychotropic Drug Historic Market Size by Type (2016-2021)
4.2 Global Psychotropic Drug Forecasted Market Size by Type (2022-2027)

5 Psychotropic Drug Breakdown Data by Application
5.1 Global Psychotropic Drug Historic Market Size by Application (2016-2021)
5.2 Global Psychotropic Drug Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Psychotropic Drug Market Size (2016-2027)
6.2 North America Psychotropic Drug Market Size by Type
6.2.1 North America Psychotropic Drug Market Size by Type (2016-2021)
6.2.2 North America Psychotropic Drug Market Size by Type (2022-2027)
6.2.3 North America Psychotropic Drug Market Size by Type (2016-2027)
6.3 North America Psychotropic Drug Market Size by Application
6.3.1 North America Psychotropic Drug Market Size by Application (2016-2021)
6.3.2 North America Psychotropic Drug Market Size by Application (2022-2027)
6.3.3 North America Psychotropic Drug Market Size by Application (2016-2027)
6.4 North America Psychotropic Drug Market Size by Country
6.4.1 North America Psychotropic Drug Market Size by Country (2016-2021)
6.4.2 North America Psychotropic Drug Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Psychotropic Drug Market Size (2016-2027)
7.2 Europe Psychotropic Drug Market Size by Type
7.2.1 Europe Psychotropic Drug Market Size by Type (2016-2021)
7.2.2 Europe Psychotropic Drug Market Size by Type (2022-2027)
7.2.3 Europe Psychotropic Drug Market Size by Type (2016-2027)
7.3 Europe Psychotropic Drug Market Size by Application
7.3.1 Europe Psychotropic Drug Market Size by Application (2016-2021)
7.3.2 Europe Psychotropic Drug Market Size by Application (2022-2027)
7.3.3 Europe Psychotropic Drug Market Size by Application (2016-2027)
7.4 Europe Psychotropic Drug Market Size by Country
7.4.1 Europe Psychotropic Drug Market Size by Country (2016-2021)
7.4.2 Europe Psychotropic Drug Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Psychotropic Drug Market Size (2016-2027)
8.2 Asia-Pacific Psychotropic Drug Market Size by Type
8.2.1 Asia-Pacific Psychotropic Drug Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Psychotropic Drug Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Psychotropic Drug Market Size by Type (2016-2027)
8.3 Asia-Pacific Psychotropic Drug Market Size by Application
8.3.1 Asia-Pacific Psychotropic Drug Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Psychotropic Drug Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Psychotropic Drug Market Size by Application (2016-2027)
8.4 Asia-Pacific Psychotropic Drug Market Size by Region
8.4.1 Asia-Pacific Psychotropic Drug Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Psychotropic Drug Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Psychotropic Drug Market Size (2016-2027)
9.2 Latin America Psychotropic Drug Market Size by Type
9.2.1 Latin America Psychotropic Drug Market Size by Type (2016-2021)
9.2.2 Latin America Psychotropic Drug Market Size by Type (2022-2027)
9.2.3 Latin America Psychotropic Drug Market Size by Type (2016-2027)
9.3 Latin America Psychotropic Drug Market Size by Application
9.3.1 Latin America Psychotropic Drug Market Size by Application (2016-2021)
9.3.2 Latin America Psychotropic Drug Market Size by Application (2022-2027)
9.3.3 Latin America Psychotropic Drug Market Size by Application (2016-2027)
9.4 Latin America Psychotropic Drug Market Size by Country
9.4.1 Latin America Psychotropic Drug Market Size by Country (2016-2021)
9.4.2 Latin America Psychotropic Drug Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Psychotropic Drug Market Size (2016-2027)
10.2 Middle East & Africa Psychotropic Drug Market Size by Type
10.2.1 Middle East & Africa Psychotropic Drug Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Psychotropic Drug Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Psychotropic Drug Market Size by Type (2016-2027)
10.3 Middle East & Africa Psychotropic Drug Market Size by Application
10.3.1 Middle East & Africa Psychotropic Drug Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Psychotropic Drug Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Psychotropic Drug Market Size by Application (2016-2027)
10.4 Middle East & Africa Psychotropic Drug Market Size by Country
10.4.1 Middle East & Africa Psychotropic Drug Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Psychotropic Drug Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Psychotropic Drug Introduction
11.1.4 Pfizer Revenue in Psychotropic Drug Business (2016-2021)
11.1.5 Pfizer Recent Development
11.2 Ely Lilly
11.2.1 Ely Lilly Company Details
11.2.2 Ely Lilly Business Overview
11.2.3 Ely Lilly Psychotropic Drug Introduction
11.2.4 Ely Lilly Revenue in Psychotropic Drug Business (2016-2021)
11.2.5 Ely Lilly Recent Development
11.3 Actavis
11.3.1 Actavis Company Details
11.3.2 Actavis Business Overview
11.3.3 Actavis Psychotropic Drug Introduction
11.3.4 Actavis Revenue in Psychotropic Drug Business (2016-2021)
11.3.5 Actavis Recent Development
11.4 Mylan
11.4.1 Mylan Company Details
11.4.2 Mylan Business Overview
11.4.3 Mylan Psychotropic Drug Introduction
11.4.4 Mylan Revenue in Psychotropic Drug Business (2016-2021)
11.4.5 Mylan Recent Development
11.5 Randox
11.5.1 Randox Company Details
11.5.2 Randox Business Overview
11.5.3 Randox Psychotropic Drug Introduction
11.5.4 Randox Revenue in Psychotropic Drug Business (2016-2021)
11.5.5 Randox Recent Development
11.6 Fujifilm
11.6.1 Fujifilm Company Details
11.6.2 Fujifilm Business Overview
11.6.3 Fujifilm Psychotropic Drug Introduction
11.6.4 Fujifilm Revenue in Psychotropic Drug Business (2016-2021)
11.6.5 Fujifilm Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Psychotropic Drug Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics
Table 3. Key Players of Anesthetics
Table 4. Key Players of Hypnotics
Table 5. Key Players of Others
Table 6. Global Psychotropic Drug Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Psychotropic Drug Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Psychotropic Drug Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Psychotropic Drug Market Share by Regions (2016-2021)
Table 10. Global Psychotropic Drug Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Psychotropic Drug Market Share by Regions (2022-2027)
Table 12. Psychotropic Drug Market Trends
Table 13. Psychotropic Drug Market Drivers
Table 14. Psychotropic Drug Market Challenges
Table 15. Psychotropic Drug Market Restraints
Table 16. Global Psychotropic Drug Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Psychotropic Drug Market Share by Players (2016-2021)
Table 18. Global Top Psychotropic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Drug as of 2020)
Table 19. Ranking of Global Top Psychotropic Drug Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Psychotropic Drug Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Psychotropic Drug Product Solution and Service
Table 23. Date of Enter into Psychotropic Drug Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Psychotropic Drug Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Psychotropic Drug Revenue Market Share by Type (2016-2021)
Table 27. Global Psychotropic Drug Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Psychotropic Drug Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Psychotropic Drug Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Psychotropic Drug Revenue Market Share by Application (2016-2021)
Table 31. Global Psychotropic Drug Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Psychotropic Drug Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Psychotropic Drug Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Psychotropic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Psychotropic Drug Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Psychotropic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Psychotropic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Psychotropic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Psychotropic Drug Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Psychotropic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Psychotropic Drug Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Psychotropic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Psychotropic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Psychotropic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Psychotropic Drug Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Psychotropic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Psychotropic Drug Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Psychotropic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Psychotropic Drug Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Psychotropic Drug Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Psychotropic Drug Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Psychotropic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Psychotropic Drug Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Psychotropic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Psychotropic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Psychotropic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Psychotropic Drug Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Psychotropic Drug Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Psychotropic Drug Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Psychotropic Drug Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Psychotropic Drug Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Psychotropic Drug Market Size by Country (2022-2027) & (US$ Million)
Table 63. Pfizer Company Details
Table 64. Pfizer Business Overview
Table 65. Pfizer Psychotropic Drug Product
Table 66. Pfizer Revenue in Psychotropic Drug Business (2016-2021) & (US$ Million)
Table 67. Pfizer Recent Development
Table 68. Ely Lilly Company Details
Table 69. Ely Lilly Business Overview
Table 70. Ely Lilly Psychotropic Drug Product
Table 71. Ely Lilly Revenue in Psychotropic Drug Business (2016-2021) & (US$ Million)
Table 72. Ely Lilly Recent Development
Table 73. Actavis Company Details
Table 74. Actavis Business Overview
Table 75. Actavis Psychotropic Drug Product
Table 76. Actavis Revenue in Psychotropic Drug Business (2016-2021) & (US$ Million)
Table 77. Actavis Recent Development
Table 78. Mylan Company Details
Table 79. Mylan Business Overview
Table 80. Mylan Psychotropic Drug Product
Table 81. Mylan Revenue in Psychotropic Drug Business (2016-2021) & (US$ Million)
Table 82. Mylan Recent Development
Table 83. Randox Company Details
Table 84. Randox Business Overview
Table 85. Randox Psychotropic Drug Product
Table 86. Randox Revenue in Psychotropic Drug Business (2016-2021) & (US$ Million)
Table 87. Randox Recent Development
Table 88. Fujifilm Company Details
Table 89. Fujifilm Business Overview
Table 90. Fujifilm Psychotropic Drug Product
Table 91. Fujifilm Revenue in Psychotropic Drug Business (2016-2021) & (US$ Million)
Table 92. Fujifilm Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Psychotropic Drug Market Share by Type: 2020 VS 2027
Figure 2. Analgesics Features
Figure 3. Anesthetics Features
Figure 4. Hypnotics Features
Figure 5. Others Features
Figure 6. Global Psychotropic Drug Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail Pharmacies Case Studies
Figure 9. Online Pharmacies Case Studies
Figure 10. Psychotropic Drug Report Years Considered
Figure 11. Global Psychotropic Drug Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Psychotropic Drug Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Psychotropic Drug Market Share by Regions: 2020 VS 2027
Figure 14. Global Psychotropic Drug Market Share by Regions (2022-2027)
Figure 15. Global Psychotropic Drug Market Share by Players in 2020
Figure 16. Global Top Psychotropic Drug Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Psychotropic Drug as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Psychotropic Drug Revenue in 2020
Figure 18. Global Psychotropic Drug Revenue Market Share by Type (2016-2021)
Figure 19. Global Psychotropic Drug Revenue Market Share by Type (2022-2027)
Figure 20. North America Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Psychotropic Drug Market Share by Type (2016-2027)
Figure 22. North America Psychotropic Drug Market Share by Application (2016-2027)
Figure 23. North America Psychotropic Drug Market Share by Country (2016-2027)
Figure 24. United States Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Psychotropic Drug Market Share by Type (2016-2027)
Figure 28. Europe Psychotropic Drug Market Share by Application (2016-2027)
Figure 29. Europe Psychotropic Drug Market Share by Country (2016-2027)
Figure 30. Germany Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Psychotropic Drug Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Psychotropic Drug Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Psychotropic Drug Market Share by Region (2016-2027)
Figure 40. China Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Psychotropic Drug Market Share by Type (2016-2027)
Figure 48. Latin America Psychotropic Drug Market Share by Application (2016-2027)
Figure 49. Latin America Psychotropic Drug Market Share by Country (2016-2027)
Figure 50. Mexico Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Psychotropic Drug Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Psychotropic Drug Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Psychotropic Drug Market Share by Country (2016-2027)
Figure 56. Turkey Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Psychotropic Drug Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Pfizer Revenue Growth Rate in Psychotropic Drug Business (2016-2021)
Figure 60. Ely Lilly Revenue Growth Rate in Psychotropic Drug Business (2016-2021)
Figure 61. Actavis Revenue Growth Rate in Psychotropic Drug Business (2016-2021)
Figure 62. Mylan Revenue Growth Rate in Psychotropic Drug Business (2016-2021)
Figure 63. Randox Revenue Growth Rate in Psychotropic Drug Business (2016-2021)
Figure 64. Fujifilm Revenue Growth Rate in Psychotropic Drug Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界のスニチニブ薬市場規模・現状・予測（2021年-2027年）

Global Sunitinib Drug Market Size, Status and Forecast 2021-2027
QFJ1-6026 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、スニチニブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（12.5mgカプセル、25mgカプセル、37.5mgカプセル、50mgカプセル）、用途別市場規模（腎臓がん、GIST、pNET）、主要地域別...

世界のアンブリセンタン薬市場規模・現状・予測（2021年-2027年）

Global Ambrisentan Drug Market Size, Status and Forecast 2021-2027
QFJ1-5574 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、アンブリセンタン薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（5mg錠、10mg錠）、用途別市場規模（病院、薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界のノイラミニダーゼ阻害薬市場規模・現状・予測（2021年-2027年）

Global Neuraminidase Inhibitors Drug Market Size, Status and Forecast 2021-2027
QFJ1-5878 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、ノイラミニダーゼ阻害薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（オセルタミビル、ザナミビル、ペラミビル、ラニナミビル）、用途別市場規模（病院薬局、小売薬局、オンライン薬局、その他）、主要地域別市...

世界のパルボシクリブ薬市場規模・現状・予測（2021年-2027年）

Global Palbociclib Drug Market Size, Status and Forecast 2021-2027
QFJ1-5925 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、パルボシクリブ薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（錠剤タイプパルボシクリブ薬、カプセルタイプパルボシクリブ薬）、用途別市場規模（病院、診断センター、研究所）、主要地域別市場規模（北米、ア...

世界の抗レトロウイルス薬市場規模・現状・予測（2021年-2027年）

Global Antiretroviral Drug Market Size, Status and Forecast 2021-2027
QFJ1-5589 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、抗レトロウイルス薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（多剤併用、NRTI、NNRTI、プロテアーゼ阻害剤、その他）、用途別市場規模（病院、製薬会社、その他）、主要地域別市場規模（北米、アメ...

世界のアテローム性動脈硬化症薬市場規模・現状・予測（2021年-2027年）

Global Atherosclerosis Drug Market Size, Status and Forecast 2021-2027
QFJ1-3865 2021年6月 107Pages
QYResearch社発行の本調査レポートでは、アテローム性動脈硬化症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗血小板薬、コレステロール低下薬、フィブリン酸＆オメガ-3脂肪酸誘導体、その他）、用途別市場規模（小売薬局、病院薬局、オンライン...

世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年）

Global Cutaneous Radiation Injury Drug Market Size, Status and Forecast 2021-2027
QFJ1-4082 2021年6月 100Pages
QYResearch社発行の本調査レポートでは、皮膚放射線傷害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、外用薬）、用途別市場規模（病院薬局、オンライン薬局、小売薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国...

世界のB型肝炎治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Drug Market Size, Status and Forecast 2021-2027
QFJ1-5776 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）、...

世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年）

Global Hepatitis B Therapeutic Drug Market Size, Status and Forecast 2021-2027
QFJ1-5777 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、B型肝炎用治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（エンテカビル、テノホビル、ラミブジン、アデフォビル、テルビブジン、その他）、用途別市場規模（病院薬局、小売薬局＆ドラッグストア、その他）...

世界の鎮痙薬市場規模・現状・予測（2021年-2027年）

Global Antispasmodics Drug Market Size, Status and Forecast 2021-2027
QFJ1-3839 2021年6月 106Pages
QYResearch社発行の本調査レポートでは、鎮痙薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ジシクロミン塩酸塩、ロペラミド塩酸塩、その他）、用途別市場規模（病院、ホームケア、専門診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、...

世界のアテローム性動脈硬化症薬市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Atherosclerosis Drug Market The global Atherosclerosis Drug market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report m…
世界の皮膚放射線傷害治療薬市場規模・現状・予測（2021年-2027年） Cutaneous radiation injury occurs on a functional, cellular, and gross level. Radiation therapy is the major modality in the management of cancer treatment along with the surgery and chemotherapy. Most common side effect of the radiation is the acute skin reaction which usually range from mild to co…
世界のB型肝炎治療薬市場規模・現状・予測（2021年-2027年） Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver. Market Ana…
世界のスニチニブ薬市場規模・現状・予測（2021年-2027年） Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on J…
世界のB型肝炎用治療薬市場規模・現状・予測（2021年-2027年） Treatment for chronic hepatitis B may include: Antiviral medications. Several antiviral medications — including entecavir (Baraclude), tenofovir (Viread), lamivudine (Epivir), adefovir (Hepsera) and telbivudine (Tyzeka) — can help fight the virus and slow its ability to damage your liver. Market Ana…